Regen BioPharma, Inc. (RGBP) Research

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Market snapshot

Symbol
RGBP
Price
$0.00
Day change
+100.00%
Market cap
$6.3K
P/E ratio
-0.05x
52-week range
0.0001-0.1169
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • THC Farmaceuticals, Inc. (CBDG)
  • ChitogenX Inc. (CHNXF)
  • Dental Patient Care America, Inc. (DPAT)
  • Innovation Pharmaceuticals Inc. (IPIX)
  • Levitee Labs Inc. (LVTTF)
  • Nascent Biotech, Inc. (NBIO)
  • Actavia Life Sciences, Inc. (RASP)
  • RespireRx Pharmaceuticals Inc. (RSPI)

Open Regen BioPharma, Inc. (RGBP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.